Hospitals Weigh ROI of RFID and RTLS for Smarter Medication Management
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare strategy lead, and Annika Matas, senior director of product management and…
FDA Blocks Compounded GLP-1 Ingredients, RSV Vaccination Benefits Seniors, and Pharmacies Struggle With Pricing Program
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering new FDA restrictions on GLP-1 compounding, fresh…
Transforming Hospital Pharmacy Inventory Management
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare strategy lead, and Annika Matas, senior director of product management and…
Gilead Expands R&D Hub, WHO Adds GLP-1s to Essential Medicines List, and High-Dose Flu Vaccine Shows Heart Benefits
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering Gilead’s latest expansion in R&D, a milestone…
Amgen Invests $600M in Innovation Hub, Novartis Collaborates With Argo, and Wegovy Tops Tirzepatide in Heart Outcomes
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering a major R&D investment from Amgen, a…
AI’s New Role in Pharma Strategy
Avinob Roy, Vice President & General Manager of Global Commercial Product Offerings at IQVIA, spoke with Pharmaceutical Commerce about how advancements in AI, particularly agentic AI, are reshaping the future of commercial operations in life sciences. From understanding disease landscapes…
Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power
Image Credit: Adobe Stock Images/Philip.com Last night, the Trump administration requested that the US Supreme Court hear out an appeal to overturn a previous ruling by a lower court declaring that a majority of his tariffs are null and void.1,2…
Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation
Image Credit: Adobe Stock Images/SundryPhotography.com Gilead Sciences has unveiled its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC), nestled in the company’s Foster City, CA headquarters.1 The new 180,000 square-foot plant spans five stories, and represents another accomplished…
How Drug Shortages Could Disrupt Hospital Operations and Strain Patient Care
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In a video interview with Pharma Commerce, Boyede Sobitan, global healthcare strategy lead, and Annika Matas, senior director of product management and…
Trump Appeals Tariff Ruling, Sanofi Shares Slide on Trial Miss, and COVID-19 Alters Pneumococcal Mortality
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering the latest legal battle over pharmaceutical tariffs,…
Overcoming Barriers to Full e-Prescribing Adoption
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because it represents rare bipartisan agreement on an issue that directly impacts both healthcare providers and patients. In a video interview…
Amgen Invests $600M in Innovation Hub, Novartis Buys Argo for $5.2B, and Wegovy Tops Tirzepatide in Heart Outcomes
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering a major R&D investment from Amgen, a…
Why Reducing Paper Inserts Is About Access as Much as Sustainability
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because it represents rare bipartisan agreement on an issue that directly impacts both healthcare providers and patients. In a video interview…
FDA Approves Sanofi’s Wayrilz, OTC Triptans Show Public Health Gains, and Biosimilar Rules Streamlined
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re looking at a new FDA approval in rare…
Modernizing Prescription Information
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because it represents rare bipartisan agreement on an issue that directly impacts both healthcare providers and patients. In a video interview…
Flu Vaccination Rates Improve, AI Powers RNA Therapeutics, and Statin Intolerance Spurs Self-Medication Risks
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re highlighting encouraging progress in flu vaccination rates, a…
Pharma Supply Chain Faces Risks of Tariffs Driving Excess Inventory
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect depends heavily on where in the supply chain the tariff…
Child Vaccines Show Adult Protection, Lilly Pauses Mounjaro Shipments, and FDA Rejects Lytenava Resubmission
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering new research on vaccine protection, Eli Lilly’s…
The Great Pharma Reshoring
This video was created based on various Pharma Commerce articles: AbbVie Invests $195 Million to Expand Stateside API Manufacturing AstraZeneca Commits $50 Billion to US Manufacturing and R&D Efforts by 2030 Battelle and Aprecia Partner With HHS and DARPA to…
CDC Director Pushback, Persistent Drug Shortages, and FDA Clears First Generic GLP-1 for Weight Loss
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering a high-profile leadership dispute at the CDC,…
Mitigating Pharmaceutical Supply Chain Challenges
Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business, outlines examples of obstacles faced by the pharma supply chain, supply chain vulnerabilities, and lessons learned in risk mitigation, while…
Pharmaceutical Commerce Presents The Most Favored Nation Mandate
Pharmaceutical Commerce presents The Most Favored Nation Mandate webinar! Earlier this year, Donald Trump issued an executive order stating that pharma companies must treat the United States as a most-favored-nation (MFN). Essentially, the order states that drug prices in the…
Eli Lilly Pauses UK Mounjaro Shipments Ahead of 170% Price Hike
Image Credit: Adobe Stock Images/KKStock.com With an increase in price forthcoming, Eli Lilly has decided to temporarily pause UK shipments of Mounjaro1—the company’s branded form of tirzepatide that is approved for the treatment of type 2 diabetes in adults—until Sept….
Cold Chain Technologies Expands APAC Presence With New Hubs, Distributors, and Manufacturing Investment
Image Credit: Cold Chain Technologies Cold Chain Technologies (CCT), is solidifying its commitment to growing its Asia-Pacific (APAC) presence by continuing to seek out new investment and partnership opportunities across the region.1 These new initiatives aim to combine CCT’s global…
Balancing Tariffs and Patient Access in Pharma Policy
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect depends heavily on where in the supply chain the tariff…
ACOG Reaffirms COVID-19 Vaccine in Pregnancy, SGLT2 Real-World Safety Data, and EVERSANA–Waltz Tackle Drug Costs
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering updates in maternal health guidance, real-world diabetes…
FDA Greenlights New COVID Vaccines, Sets Eligibility Limits
Credit: Tada Images | stock.adobe.com The FDA has authorized the use of updated COVID-19 vaccines for the upcoming fall season, with eligibility limited to adults aged 65 years and older as well as individuals who have at least one underlying…
FDA Boosts Transparency, CDC Appoints mRNA Critic, and Genentech Invests $700M in US Manufacturing
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering new steps from the FDA to expand…
AI Fuels Surge in Counterfeit Drug Websites
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by bad actors leveraging artificial intelligence (AI). Counterfeiters are now using…
Novo Nordisk Plant Faces FDA Scrutiny, Off-Label GLP-1 Use Grows, and AbbVie Expands Psychiatry Pipeline
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering FDA safety concerns at a major Novo…
Novo Nordisk’s Indiana Plant Flagged by FDA for Contamination and Safety Lapses
Image Credit: Adobe Stock Images/TadaImages.com Novo Nordisk has some facility issues to address. As first reported by STAT News,1 the company’s Bloomington, IN plant that was acquired as part of last year’s Catalent acquisition2 has received an FDA Form 483….
CVS Caremark Faces $290M Penalty, Small Practices Miss HIPAA Standards, and Pharmacists Underreport Adverse Drug Reactions
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering a major legal ruling against CVS Caremark,…
Johnson & Johnson Commits $2 Billion to North Carolina Manufacturing Expansion
Image Credit: Adobe Stock Images/MichaelVi.com Johnson & Johnson is all in on domestic manufacturing. The company announced plans to boost its North Carolina presence by constructing a 160,0000-plus-square-foot manufacturing facility at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, NC.1 The…
Combating Counterfeit Medicines Requires AI Integration and Industry Collaboration
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by bad actors leveraging artificial intelligence (AI). Counterfeiters are now using…
Pharma Tariffs Take Shape, J&J Invests $2 Billion in US Manufacturing, and New EHR Rule Targets Prior Authorization
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering updates on international trade, a US manufacturing…
CVS Caremark Ordered to Pay $290 Million in False Claims Act Whistleblower Case
Image Credit: Adobe Stock Images/ImagingL.com Following an eight-day bench trial, a judge has issued a final judgement ruling that pharmacy benefits manager Caremark—a subsidiary of CVS Health—must pay $289.9 million in damages to Sarah Behnke, in a False Claims Act whistleblower…
Building the Next-Generation Supply Chain Talent Pipeline (Episode 9)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
Pharma Regulatory Strategies Could Shift as Vaccine Support Declines
In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new lawsuit filed by leading medical organizations to restore access to COVID-19 vaccines for children and pregnant people. Lanton explained how the…
White House and EU Finalize Trade Deal With 15% Cap on Pharma Tariffs
Image Credit: Adobe Stock Images/Aquir.com As noted by Pharm Exec,1 the White House and European Union today revealed a framework for a deal centered around “reciprocal, fair, and balanced trade” that is expected to get into effect Sept. 1 of…
Catalent to Lay Off 350 Workers at Baltimore Gene Therapy Plant
Image Credit: Adobe Stock Images/PostmodernStudio.com Endpoints News coverage1 has reported that Catalent, a global contract development and manufacturing organization (CDMO), is downsizing. The CDMO cites an “unexpected shift in demand from a large customer,” and will be laying off 350…
New Technologies Drive Down Pharma Manufacturing Costs in the United States
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect depends heavily on where in the supply chain the tariff…
Battelle and Aprecia Partner With HHS and DARPA to Advance Agile Drug Manufacturing
Image Credit: Adobe Stock Images/Parintron.com Via financial support from the US Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR) Office of Industrial Base Management and Supply Chain (IBMSC), Battelle, an independent, non-profit applied science…
AI-Powered Tools Transform Fight Against Counterfeit Drugs
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by bad actors leveraging artificial intelligence (AI). Counterfeiters are now using…
Monitoring Payer-Level Performance and Planning
Payer-focused reporting should not just identify winners and losers, but rather, it should drive a benchmarking process that informs strategy and guides activity. Embracing this maxim means that executive-level reports should answer two questions: Performance and position: Which payers are…
Counterfeiters Target Fragmented Pharma Supply Chains Through Digital Marketplaces
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by bad actors leveraging artificial intelligence (AI). Counterfeiters are now using…
How a 250% Tariff Might Ripple Through Pharma Supply Chains and Spur Domestic Production
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect depends heavily on where in the supply chain the tariff…
The Tariff Saga Continues
It’s been about six months since the trade wars pitting the US vs. various global nations and regions have commenced, and in my unbiased opinion, Pharmaceutical Commerce has done as exceptional of a job as any news outlet in providing…
US API Stockpile Plan, Mounjaro Price Hike in UK, and New Data on Vaccine Safety
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering three major developments—from new US policy on…
Gross-to-Net Bubble Reshapes Drug Pricing Strategy
This video was created based on Bill Roth’s “Popping the Gross-to-Net Bubble” article series. Welcome to the explainer. Today, we are talking about the wild and honestly, super complex world of drug pricing, and we’re going to tackle what some…
Goodpath Partners With GiftHealth to Expand Access to GLP-1 Therapies Through LillyDirect
Image Credit: Adobe Stock Images/Thanayut.com Goodpath, a virtual clinic for chronic health conditions, has reached a pharmacy integration deal with GiftHealth, Eli Lilly and Company’s LillyDirect pharmacy provider.1 LillyDirect is Lilly’s direct-to-consumer digital healthcare platform that was launched back in January 2024.2 It’s…
Pharma Leaders Stress Tailored, Balanced Approach to Long-Term Manufacturing Strategy (Episode 8)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
A Pharma Wholesaler Scorecard
Mike Hennessy Jr, chairman and CEO, MJH Life Sciences Every stakeholder’s role in the pharmaceutical supply chain is just as important as the next, and that certainly holds true for that of the drug wholesaler. Essentially, these businesses serve as…
Pharmaceutical Commerce: August 2025 Interactive Digital Edition
View the Pharmaceutical Commerce August 2025 issue in an interactive format.
340B Litigation and the Path Toward Transparent Drug Discount Programs
340B: Recent Timeline July 31, 2025: HRSA launches 340B Rebate Model Pilot. The US Health Resources & Services Administration (HRSA) formally opened a voluntary Rebate Model Pilot Program, inviting select drugmakers to apply to implement retrospective rebates—instead of upfront discounts—for…
AI-Powered Counterfeit Drug Schemes Pose Growing Threat to Patient Safety
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication of the counterfeit pharmaceutical market, driven in large part by bad actors leveraging artificial intelligence (AI). Counterfeiters are now using…
Questions Patient Access Leaders Should Be Asking About AI (But Aren’t)
Key Takeaways Pharma brands should evaluate AI in patient services by asking outcome-focused questions—how it improves patient care and brand performance—not just how it reduces costs. Effective AI solutions should preserve human touchpoints, have clear escalation paths when automation fails,…
Potential 250% Pharma Tariffs Could Pressure Margins Without Directly Raising Patient Costs
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a proposed 250% tariff on pharmaceutical imports, emphasizing that the effect depends heavily on where in the supply chain the tariff…
Insurance Barriers Delaying Patient Care
Key Takeaways Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated health plan access a “D,” with nearly half facing insurance-related barriers like high cost-sharing, formulary restrictions, and prior authorization. Barriers…
Balancing AI Ambition With Cost Pressures in Pharma
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big Beautiful Bill Act (OBBBA) is expected to significantly influence prescription drug spending by reshaping access and reimbursement within Medicaid, certain…
Novo Nordisk Ramps Up Legal Fight Against Compounded Semaglutide Knockoffs
Image Credit: Adobe Stock Images/Ibnu.com Novo Nordisk recently filed 14 new lawsuits intended to protect patients from unapproved compounded drugs that falsely claim to contain semaglutide. The defendants that are mentioned in the lawsuits claim that these compounded products have…
Ways Pharma Supply Chains Can Cut Scope 3 Emissions Now
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and physician offices. This…
Noom Debuts Microdose GLP-1 Program to Help Reduce Side Effects and Boost Affordability
Image Credit: Adobe Stock Images/Ishika.com Noom, an online weight loss company, is unveiling its Microdose GLP-1Rx Program, a service intended to limit side effects via personalized microdoses of GLP-1s, when clinically appropriate of course.1 The initial price of the program is…
Lessons From Shortages and Global Disruptions
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and physician offices. This…
Esteve Expands US Footprint With Acquisition of Regis Technologies, Boosts Rare Disease Portfolio
Image Credit: Adobe Stock Images/JozefMicic.com Esteve has purchased Regis Technologies, a Chicago-based contract development and manufacturing organization (CDMO), for an undisclosed amount.1 The deal provides Esteve CDMO—a Spain-based, third-party CDMO that operates under the Esteve Química brand—the opportunity to have a…
Pharma Industry Shifts Toward Full Activation
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and…
What Clinical Ops Teams Must Know About Biomarkers in Trials; What is the Timeline for True AI Implementation for Digital Twins?
What Clinical Ops Teams Must Know About Biomarkers in Trials In an interview with Applied Clinical Trials, Michael Miller, COO of Quanterix, emphasized that clinical operations teams must carefully consider the purpose, technical requirements, and regulatory implications of biomarkers in…
Balancing Compliance and Supply Chain Continuity
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how today’s distribution networks must seamlessly connect manufacturers to care sites that range from large academic centers to rural pharmacies and…
How Grocery-Based Pharmacies are Evolving into Community Health Hubs
Image Credit: Adobe Stock Images/AMuhSakaria.com As large pharmacy retailers scale back operations, community pharmacies—particularly those embedded within grocery stores—are stepping into expanded roles as accessible healthcare touchpoints. This shift reflects a broader trend toward integrating healthcare services into everyday consumer…
FDA Delays Regeneron’s Odronextamab, Eylea HD Regulatory Decisions Over Catalent Site Issues
Credit: Ascannio | stock.adobe.com. The FDA has issued a second complete response letter (CRL) to Regeneron’s odronextamab based on issues with a third-party manufacturing site, Catalent Indiana LLC, the company announced in its Q2 earnings report.1 Regeneron’s Biologics License Application…
Trump’s MFN Drug Pricing Push Targets 17 Big Pharma Companies, Spurs Global Industry Response
As reported by Pharma Commerce sister publication, Pharmaceutical Executive,1 President Trump recently issued letters to 17 of the largest pharmaceutical companies, expressing urgency for making changes along the drug pricing front. These letters stem from an executive order (EO) he…
Leveraging Technology to Strengthen Pharma’s Fight Against Counterfeits (Episode 6)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
As Trump Pharma Tariff Deadline Looms, Here’s How the Sector Got Here
Image Credit: Adobe Stock Images/PeopleGraphics.com As the month of July winds down, the trade wars featuring the United States versus all other nations have been in full swing for about six months now. This had been kicked off by President…
Emission-Reduction Strategies That Save Money and Preserve Performance
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical industry, particularly across warehousing, packaging, and outbound transportation. Chenenko defines…
High Out-of-Pocket Costs Burden Privately Insured Cancer Patients, Study Finds
With there being challenges in analyzing OOPCs that were related to certain cancer diagnoses in patients that privately insured, a retrospective cohort study published in JAMA Network Open sought toinvestigate this further. Image Credit: Adobe Stock Images/CDavids/peopleimages.com It is no…
Tackling ESG Data Gaps in Supplier and Third-Party Reporting
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical industry, particularly across warehousing, packaging, and outbound transportation. Chenenko defines…
United States, European Union Reach Trade Pact
President Trump reached a formal trade agreement with the European Union in which a maximum 15% levy will be imposed on “most” EU exports, including autos and their parts; semiconductors; and pharmaceuticals. Image Credit: Adobe Stock Images/RealisticAIStudio.com Earlier this week,…
Weighing Cost Savings Against Safety and Regulatory Risks
In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem, including commercial insurers and Medicaid, exhibits a divided approach when it comes to supporting access to obesity medications. Coverage largely…
How CGT Developers Can Overcome Market Access, Regulatory, and Commercialization Hurdles
PC: As CGTs expand to serve broader patient populations, what strategies can developers use to overcome market access barriers such as payer skepticism and limited reimbursement pathways? Kevin Chinn: Central to overcoming the challenges is the need to increase payer…
Unlocking Sustainability Across the Supply Chain
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of Scope 3 emissions and their growing relevance in the pharmaceutical industry, particularly across warehousing, packaging, and outbound transportation. Chenenko defines…
Recapping the Sarepta Saga—And Implications for Industry
The controversy surrounding embattled gene therapy company Sarepta Therapeutics, including its drug, Elevidys, for Duchenne muscular dystrophy, continues to captivate industry observers—with the latest twist being Sarepta’s decision late Monday to voluntarily pause Elevidys shipments in the US. Monday’s action…
Balancing DEI Reporting with Legal Risk; What the Emrelis Approval Means for Pharma and Biotech ADC Strategies
Balancing DEI Reporting with Legal Risk In an interview with Applied Clinical Trials, Kate Gallin Heffernan, a life sciences attorney at Epstein Becker Green, discussed how clinical research teams can balance accurate DEI-related reporting with minimizing legal risk, emphasizing the…
How Pharma Executives Can Prepare for Tariff Uncertainty
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused…
How Life Sciences Firms Are Evolving to Navigate Trade, Tariff, and Pricing Turbulence
Sixty percent of life sciences and healthcare leaders are anticipating that the current or forthcoming tariffs and pricing policies will have “some impact” on their businesses. Image Credit: Adobe Stock Images/Thanawat_Suesoypan.com According to the Deloitte Center for Health Solutions’ “2025…
Supply Chain Blind Spots Threatening Pharma Integrity (Episode 5)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
Cold Chain Technologies, E&I Cooperative Services Strike Deal to Provide Schools with Expedited Access to Cold Chain Solutions
Image Credit: Adobe Stock Images/Sardar Key Takeaways Expanded Educational Access: Cold Chain Technologies (CCT) partners with E&I Cooperative Services to provide over 6,000 educational institutions expedited access to advanced cold chain packaging solutions. Streamlined Procurement Process: The partnership enables members…
Leveraging Digital Twins and Analytics to Optimize Global Pharma Supply Chains
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused…
Driving Adherence and Safety Through Digital Innovation
Patient safety and medication adherence are some of the major concerns in the pharmaceutical industry. With an increase in medication errors, counterfeit medicines, and supply chain mismanagement, the industry has seen a rising demand for transparency, security, engagement, and digitization.1…
EU Threatens 30% Tariffs on $117 Billion of US Goods Amid Trade Standoff
The European Union intends to impose a 30% tariff on US imports valued at $117 billion if a trade deal is not reached. Image Credit: Adobe Stock Images/Khwankhae.com The European Union intends to impose a 30% tariff on US imports…
Building Inventory and Navigating FDA Hurdles in a Tariff-Driven Market
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused…
The Ripple Effect of 200% Tariffs on US Drug Supply and Pricing
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff on pharmaceutical imports could have significant short- and long-term impacts on US drug manufacturing and distribution, with immediate concerns focused…
Knipper Health Purchases eBlu Solutions to Accelerate Therapy Initiation
The combination of both parties’ offerings is a platform for managing the entire journey, from order to therapy initiation. Image Credit: Adobe Stock Images/NicoElNino.com Knipper Health has purchased eBlu Solutions, a provider-integrated tech platform.1 Via its services, specialty provider practices…
Balancing Awareness and Assurance
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack of awareness among healthcare professionals (HCPs). Despite SF drugs posing…
Inside the GLP-1 Strategy Driving Competitive Edge in Obesity Clinical Research; Eisai Highlights Long-Term Efficacy of Lenvima in Advanced HCC Treatment
Inside the GLP-1 Strategy Driving Competitive Edge in Obesity Clinical Research In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of pediatrics at Parexel, discussed how the company is using…
Cracking Down on Illegal Online Pharmacies
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack of awareness among healthcare professionals (HCPs). Despite SF drugs posing…
How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies; Eisai Explores Novel Dual Mechanism Therapy for Advanced Endometrial Carcinoma
How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies In an interview with Applied Clinical Trials, Shipra Patel, global therapeutic area section head for endocrinology and global head of pediatrics at Parexel, explained how the company supports cross-functional GLP-1…
The Hidden Challenge of Reporting Counterfeit Medicines
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack of awareness among healthcare professionals (HCPs). Despite SF drugs posing…
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
Resilience, which is the concept of defying adversity and recovering from hardship, is connected to one’s health and well-being. Image Credit: Adobe Stock Images/Jaman_Visual.com Resilience, which is the concept of defying adversity and recovering from hardship, is connected to one’s…
How DSCSA Is Transforming Supply Chain Data Exchange (Episode 4)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
Trump Says Pharma Industry Should Expect Tariffs by Aug. 1
President Trump noted that the pharma sector should prepare for levies by the beginning of next month, which could coincide with the planned reciprocal tariffs rates that were previously set. Image Credit: Adobe Stock Images/FreshIdea.com Earlier this week, per Bloomberg,…
The Biosimilar Void
In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains the extensive process behind developing the “Global Use of Medicines Outlook Through 2029” report. The creation of this comprehensive resource…
Creating a Unified Strategy to Advance Education on Counterfeit Medicines
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack of awareness among healthcare professionals (HCPs). Despite SF drugs posing…
Thermo Fisher, Sanofi Expand Partnership to Boost Sterile Drug Production
Image Credit: Adobe Stock Images/ASDF Key Takeaways Strategic site acquisition: Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, expanding its US-based fill-finish capabilities. Workforce integration: More than 200 Sanofi employees will transition to Thermo Fisher…
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
The consortium will be focused on deploying novel technologies to launch a fully automated, scalable, and hyper-efficient cell therapy manufacturing platform on a global scale. Image Credit: Cellular Origins Cellular Origins, a TTP company that prioritizes the scalable, robotic production of…
Why Medical Education Must Catch Up
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack of awareness among healthcare professionals (HCPs). Despite SF drugs posing…
Knipper Health Taps Willis Chandler as New President and CEO
Chandler’s pharmaceutical experience spans years in the pharma services space, powered by strategic leadership roles. Image Credit: Knipper Health Following Frazier Healthcare Partners’ investment in Knipper Health, Willis Chandler has officially been appointed as Knipper’s president and CEO.1 How exactly…
LEO Pharma to Head Global Commercialization of Spevigo in $105M Deal with Boehringer Ingelheim
LEO Pharma will pay Boehringer Ingelheim $105.2 million (€90 million) upfront, with the opportunity for additional payment, if specific milestones are met. Image Credit: Adobe Stock Images/JHVEPhoto.com Boehringer Ingelheim and LEO Pharma have reached an exclusive global license and transfer…
Gilead, Global Fund Partner to Expand Access to Lenacapavir
Gilead plans to supply enough doses to assist up to two million individuals over three years in nations supported by the Global Fund. Image Credit: Adobe Stock Images/TobiasArhelger.com Gilead Sciences is collaborating with the Global Fund to Fight AIDS, Tuberculosis…
Reducing Healthcare Prices
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts of a federal cap on Medicaid provider taxes and how…
Removing Financial Barriers to Boost Trial Diversity; How Prescribing Power Has Shifted Beyond Physicians
Removing Financial Barriers to Boost Trial Diversity In an interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, emphasized the importance of removing financial and logistical barriers—such as through reimbursements, stipends, and prepaid travel—to improve clinical trial diversity and…
How Pharma Can Detect Supply Chain Failures Before They Happen (Episode 3)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
Despite these medications being both available and affordable, racial, ethnic, and socioeconomic disparities came to light when it came to accessing COVID-19 treatment. Image Credit: Adobe Stock Images/Steheap.com As history has shown, being able to act fast when it comes…
A Look Under the Hood of Medicaid Support
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts of a federal cap on Medicaid provider taxes and how…
Why Every Employee Needs to Be Part of the Journey
Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market. From the new drug application (NDA) submission to the Prescription Drug User…
Sustaining Regulatory Engagement Through Industry and Advocacy Collaboration
PC: In the absence of public participation at the federal level, how can industry leaders collaborate with advocacy groups to sustain meaningful engagement with regulators? Leuchter: Experienced regulators are very attuned to how patients and caregivers live day to day…
Navigating Market Entry Challenges for Orphan Drugs
July 9, 2025 Edward Ahn, CEO of MEDIPOST, Inc., reacts to the challenge of launching orphan drugs without complete evidence, particularly given their high cost and limited patient populations, and suggests strategies that can be used to address evidence gaps,…
Pharma Industry Should Brace for up to 200% Tariffs
President Trump noted that import taxes on pharmaceuticals of up to 200% could come forthcoming. Image Credit: Adobe Stock Images/MohammadXte.com The pharmaceutical industry has been anxiously standing by, waiting on the possibility that tariffs on imports entering the United States…
What Payers Really Want from High Cost Therapies in Rare Diseases
PC: How might this change affect payer negotiations and reimbursement decisions, particularly for innovative or high-cost therapies? Leuchter: When it comes to rare diseases, patients often suffer from a wide range of symptoms—some of which receive more attention from drug…
Trump Imposes 25% Tariffs on Japan, South Korea, and a Dozen Other Nations
All of the levies come with a stipulation—if these nations increase their tariffs, the United States will raise them on its end as well. Image Credit: Adobe Stock Images/Zenday.com Yesterday, per AP and CBS News,1,2 US President Donald Trump enacted…
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
A qualitative study explored how representatives from MA plans, kidney care management companies, and dialysis organizations view the expansion and marketing of MA products for individuals with ESKD. Image Credit: Adobe Stock Images/CrystalLight.com By this year, enrollment in Medicare Advantage…
Aligning Real-World Evidence with Payer Perspectives
The trust gap between real-world evidence (RWE)/data and randomized controlled trials is growing. This episode examines when each evidence type is appropriate, how to reduce perceived bias in RWE, and how payer context varies by geography and structure. Insights from…
Building Patient Centricity into Clinical Trial Software from Day One; Industry Voices on Current Pricing and Reimbursement Models
2025 DIA Annual Meeting: Building Patient Centricity into Clinical Trial Software from Day One In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer, uMotif, discussed how the company integrates patient and site feedback from the earliest stages…
Patient Engagement Is Critical to Developing Breakthrough Treatments
PC: What risks do you foresee for companies developing first-in-class therapies if patient perspectives are no longer formally incorporated into regulatory discussions? Leuchter: Eliminating patient perspectives from regulatory discussions would remove a key source of value—especially in the context of…
Preparing for CGT Launches
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress in key operational areas, noting that companies are now better…
Preparing for Federal Regulations; Funding Cuts Threaten Diversity in Clinical Research
Preparing for Federal Regulations: Q&A with John Stanford In an interview with Pharmaceutical Executive, John Stanford, executive director at Incubate, emphasized the importance of sustained investment in early-stage biotech to drive long-term innovation and ensure a robust drug development pipeline….
Leading by Example
In the fourth part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains the lessons pharma leaders in traditional therapeutic areas can learn from CGT’s highly specialized operational strategies, particularly in terms of supply…
Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials
Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment In an interview with Pharmaceutical Executive, Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, shared how insights from the company’s Oncology Care Index are shaping…
The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts
The Impact of FDA’s Ban on Compounded GLP-1s A Pharmaceutical Executive article explores how the FDA’s ban on compounded semaglutides—following stabilized supply from Novo Nordisk and Eli Lilly—has significantly disrupted access for patients who relied on these lower-cost alternatives, prompting…
Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030
This investment exemplifies Hikma’s interest in raising the volume of meds it creates and produces across its various R&D and manufacturing sites in Columbus and Cleveland, OH and in Cherry Hill and Dayton, NJ. Image Credit: Adobe Stock Images/Deep.com Hikma Pharmaceuticals USA today will be financially committing $1 billion by the…
The Evolution of the CGT Launch and Distribution Model
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress in key operational areas, noting that companies are now better…
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
Historically, new drugs were approved for a single therapeutic use. However, industry trends have shifted, with pharmaceutical companies increasingly identifying and developing additional indications for existing medicines. This approach is supported by regulatory agencies such as the FDA and EMA,…
How Patient Advocacy Is Guiding Rare Disease Drug Development
PC: What role has public participation historically played in shaping healthcare policy, and why is it important for pharma and biotech companies? Leuchter: Public participation has played a critical role, for many of the reasons I mentioned earlier. But I’d…
Medicaid’s Role in the CGT Sector
Medicaid is especially critical for children with rare diseases, due to their need for intensive specialty care and higher risk for financial distress. Image Credit: Adobe Stock Images/Ivlianna.com In the United States, Medicaid is considered the largest payer of healthcare,…
Novo Nordisk Expands Wegovy Access Through New WeightWatchers Partnership
Novo Nordisk is growing coverage of its Wegovy injection 2.4 mg in the form of a new deal with WeightWatchers that takes effect July 1. Image Credit: Adobe Stock Images/Syahrir.com Novo Nordisk is growing coverage of its Wegovy (semaglutide) injection 2.4…
Delivering Value Beyond the Trial with Real-World Evidence
Real-world evidence (RWE) is no longer optional—it’s expected. This episode dives into how payers assess RWE alongside clinical trial data, especially in competitive therapeutic areas. The panel stresses the importance of linking RWE to financial outcomes and making data relevant…
The Importance of Early Patient Feedback in Digital Endpoint Development; Developing FP&A Strategies in Today’s Environment
2025 DIA Annual Meeting: The Importance of Early Patient Feedback in Digital Endpoint Development In an interview with Applied Clinical Trials at the 2025 DIA Annual Meeting, Brian Ongioni, chief product officer, uMotif, emphasized the importance of incorporating early patient…
Supply Chain Planning in the Current CGT Climate
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress in key operational areas, noting that companies are now better…
How CRO Partnerships Are Evolving to Meet Changing Industry Demands; Don’t Fall for the Call of Placebo-Controlled Vaccine Trials
How CRO Partnerships Are Evolving to Meet Changing Industry Demands In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech, emphasized the need for CRO partnerships to become more collaborative, cost-efficient, and insight-driven in response to…
How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials; The Role of Patient Advocacy in Shaping AbbVie’s Cancer Therapies
2025 DIA Annual Meeting: How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials In an interview with Applied Clinical Trials, Brian Ongioni, chief product officer at uMotif, explained how the company integrates patient and site feedback…
Discovering AI’s Role in Drug Safety Monitoring
Pharmaceutical Commerce: FDA staff cuts have created a critical gap in adverse drug event (ADE) monitoring. With ADEs being the third leading cause of death in the United States,1 what role do you see AI playing in preventing these events,…
Developing a Manufacturing Contingency Plan (Episode 2)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
Utilizing AI in Today’s Current Landscape
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of global cell and gene therapy commercialization. Sawicki highlighted significant progress in key operational areas, noting that companies are now better…
Does Risk-Based Payment Drive Better Care in Medicare Advantage?
Investigators aimed to examine the quality and efficiency under the FFS MA and at-risk MA models as a way to measure both the quality and resources that are being utilized. Image Credit: Adobe Stock Images/SatoriStudio.com More than 50% of Medicare…
Overcoming Regulatory Barriers to Market Access
As international price referencing tightens and payer expectations rise, companies face a shrinking margin for error. The panel explores how clinical trial design and early payer engagement are key to meeting both regulatory and reimbursement demands across global markets. With…
Xcellbio, Thermo Fisher Team up to Advance Cell Therapy Manufacturing
The purpose of the partnership is to help further develop the Treg and TIL cell therapies that are intended to fight autoimmune and solid tumor diseases. Image Credit: Adobe Stock Images/Zuraara.com Xcell Biosciences (Xcellbio), an instrumentation company that focuses on…
The Hidden Costs of Zero-Premium Plan Turnover
Image Credit: Adobe Stock Images/TadaImages.com As a result of the Patient Protection and Affordable Care Act (ACA), 24.2 million people enrolled in the health insurance marketplaces this year, a record number.1 However, sustaining that coverage can potentially be a major…
Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program
Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program
Evaluate Issues Annual World Preview Report
Image Credit: Adobe Stock Images/StockMediaLabs.com Evaluate, who provides market insights for the pharma industry, has unveiled its “2025 World Preview Report,” which offers insights for the global pharmaceutical market through the year 2030.1,2 The breakdown is headlined by the prediction…
Current Perspective on Pricing and Reimbursement Models
This Peer Exchange® starts off with an introduction of the panel: Edward Ahn, CEO of MEDIPOST, Inc.; Rob Philo, Founder and CEO of Core Market Access Advisors; and Shana Gunderson Hua, PharmD, Vice President of Value & Access at Petauri…
The Art of Agility
Mike Hennessy Jr, chairman and CEO, MJH Life Sciences A common thread across our content offerings in the June issue of Pharma Commerce is the need for life sciences companies—and their supply chain partners—to be perhaps more agile than ever…
June 2025 Interactive Digital Edition
Pharmaceutical Commerce: June 2025 Interactive Digital Edition DSCSA Compliance: The Time is Now Conference Connect: Determining the Future of Specialty Pharmacy Bolstering Health Technology Assessment With the Help of AI Building Intelligent Pharma Supply Chain Management with Real-World Data Policy…
Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research
Strategic Planning in the Rebate Economy: What Pharma Must Do Now A recent Pharmaceutical Executive article outlines how, despite decades of evolving policy from OBRA ’90 to the Inflation Reduction Act, the US pharmaceutical system remains deeply reliant on manufacturer…
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment—and Sustained Investment Requires Sufficient Returns
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer at Novotech, emphasized the value of trust-based CRO-sponsor relationships and celebrated the company’s Citeline CRO Partnership of the…
Antares Vision Group Debuts AI-Powered Visual Inspection Platform
AI-GO blister inspection. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including the life sciences, and Oròbix, an artificial intelligence (AI) service company that’s part of Antares, have launched AI-GO, an AI-powered…
Understanding the Pharma Supply Chain (Episode 1)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation…
How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress
Image Credit: Adobe Stock Images/DigitalMagicVisions.com One of several public health issues of utmost importance are mental health disorders, which are quite commonplace. In the United States, millions of adults suffer from psychological distress, which can significantly impair their ability to…
Establishing Additional Transparency
In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind rising healthcare and drug costs that are not fully addressed by the MFN (Most-Favored Nation) executive order. She acknowledges that…
TekniPlex Healthcare Unveils New Barrier Protection Systems Plant
TekniPlex Healthcare, a supplier of barrier films, unit-dose containers, and more, has opened its new 200,000-square-foot facility in Madison, WI, which was made official with a ribbon-cutting ceremony last week. The new site—representing its second Madison plant—acts as the flagship location…
The Impact of Initial Coverage Choice
Image Credit: Adobe Stock Images/Rawpixel.com Data show that nearly two-thirds of Medicare beneficiaries feel that their coverage completely meets their expectations. Despite this, a recent survey also showed that 15% of Medicare beneficiaries changed their coverage in the past two…
Changing the PAP Model
The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.
Bolstering Health Technology Assessment With the Help of AI
Key Takeaways AI enhances traditional HTA by improving accuracy and efficiency. Artificial intelligence addresses key limitations of traditional health technology assessments—such as data gaps and time-intensive processes—through automation, real-time data integration, and advanced predictive modeling, leading to faster and more…
Policy Whiplash? 24 Hours in the Hub Still Matters More
Key Takeaways Speed is Critical. The first 24 hours after a prescription are crucial—nearly half of patients are lost immediately without efficient onboarding. Rapid, streamlined hub services are essential to keep patients engaged and on therapy. Digital and Multichannel Enrollment…
Raising the Alarm
Key Takeaways Lack of Awareness Among Healthcare Providers. Despite being the first line of defense, most HCPs receive little to no training on identifying counterfeit or substandard medicines, which puts patient safety at risk. Online Pharmacies Pose Significant Dangers. While…
What Is Smart Pharma Packaging?
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology into pharmaceutical packaging to enhance product identification, tracking, and patient engagement. She explains that packaging primarily involves embedding technologies such…
Navigating the Intersection of Accessibility and Measurement Integrity in eCOA; Do We Really Pay More for Prescription Drugs in the United States?
Navigating the Intersection of Accessibility and Measurement Integrity in eCOA An article in Applied Clinical Trials explores how clinical research’s shift toward patient-centered outcomes is prompting the eCOA field to reconcile long-standing tensions between accessibility and measurement integrity, calling for…
Embedded Product Intelligence’s Role in Maintaining Cold Chain Integrity
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology into pharmaceutical packaging to enhance product identification, tracking, and patient engagement. She explains that packaging primarily involves embedding technologies such…
Reviewing the Most-Favored Nation Model
Key Takeaways Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by certain OECD countries—an approach previously…
Addressing the Threat of Prescription Abandonment
Sticker shock at the pharmacy counter has become an all-too-familiar experience for both patients and providers. The rising cost of prescription medications in the United States creates a growing obstacle for millions of people. In 2022, more than 4,200 drug…
Extreme Examples of Who Grew the Bubble
Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was the pharmaceutical industry’s ability to raise drug prices year after year—enabled by loopholes in PBM contracts—rather than high launch prices…
DHL Officially Obtains CRYOPDP
Image Credit: Adobe Stock Images/Tippapatt.com Key Takeaways DHL has acquired Cryoport’s specialty courier business, CRYOPDP, for approximately $200 million, strengthening its position in temperature-controlled logistics for the life sciences sector. A strategic partnership between DHL and Cryoport has been formed…
Financial Assistance Programs and Healthcare Plan Navigation
June 12, 2025 Amy Niles, chief mission officer, PAN Foundation, provides a deep dive into patient awareness of financial assistance programs, while offering insights into health literacy related to medical plans.
Using Data to Influence Drug Pricing Policy
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the…
The Financial Burden of Alzheimer’s Disease and Related Dementias
Image Credit: Adobe Stock Images/BeaunittaVanWyk.com Key Takeaways Alzheimer’s disease affects nearly 6.9 million older U.S. adults, making it the most common form of dementia and a leading cause of long-term care needs and disability. The economic burden of ADRD is…
Bridging Access Gaps
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the…
The Connection Between Virtual Care and Language Barriers
Image Credit: Adobe Stock Images/Nattakorn.com Key Takeaways Language barriers reduce access to video-based virtual care: Adult patients facing language barriers are significantly less likely to use video visits compared to telephone visits, especially in specialist care settings. Overall virtual care…
How MFN Executive Order Could Affect International Drug Costs
PC: Although ways to decrease healthcare costs are certainly encouraged by pharma supply chain stakeholders, what potential long-term repercussions (if any) could President Trump’s MFN executive order have on the industry? Lanton: The executive order mandates that pharmaceutical companies match…
Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season
Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. Sanofi and AstraZeneca have tripled production capacity to meet growing demand. Beyfortus cut RSV hospitalizations…
Preparing for the Pharma C-Suite; America’s Vanishing Scientific Research Workforce is a Threat to Public Health
Preparing for the Pharma C-Suite In a Pharmaceutical Executive feature, Aileen Fernandes, Chief Business Officer at Arcellx, reflects on how her early roles at Morgan Stanley and Deloitte Consulting, combined with strategic career decisions and authentic leadership development, prepared her…
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them In a Pharmaceutical Executive feature, Gen Li, founder, CEO, Phesi, outlines five key challenges hindering investigator site selection in clinical trials—including unreliable performance predictions and…
How Geospatial Mapping Reveals the Impact of Pharmacy Closures
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the…
GLP-1 Drugs May be Linked to Elevated Risk of Serious Eye Disease; Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer
GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds A new observational study finds that people with diabetes taking GLP-1 drugs have a low but doubled risk of developing neovascular age-related macular degeneration, an eye…
Mapping the Hidden Costs
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the…
The Variation in Dual-Eligible Beneficiary Characteristics across Medicare Advantage Plan Types
Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment among full-benefit dual-eligible beneficiaries is rising, reaching nearly 50% by 2022. FIDE-SNP enrollees have greater health and support needs than those in other MA plan types. FIDE-SNP enrollees are more likely…
BioNTech, BMS to Co-Design and Co-Commercialize New Antibody Candidate for Various Types of Tumors
Image Credit: Adobe Stock Images/Hugnaka.com Key Takeaways BioNTech and Bristol Myers Squibb have entered a major global collaboration to co-develop and co-commercialize BNT327, a bispecific antibody for solid tumors, with $1.5B upfront, $2 billion total in non-contingent anniversary payments through…
Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization; Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma
Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization A Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes for patients with rare diseases—like cystic fibrosis—by providing faster access to treatment, better medication adherence,…
Driving Supply Chain Resilience
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain…
Greater Supply Chain Prepares for Repercussions
Image Credit: Adobe Stock Images/Somneuk.com Key Takeaways Tariffs could spike drug costs: Proposed 25% tariffs on pharmaceuticals may raise US drug prices by up to 12.9% and cost the industry an estimated $51 billion annually. Supply chain disruption is growing:…
Overcoming Legacy Systems
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain…
Why CX Is a Difference Maker for Pharma
Key Takeaways Exceptional CX significantly boosts engagement with healthcare professionals and consumers, leading to increased prescriptions, better market penetration, and improved health outcomes. Pharma companies are leveraging AI-driven omnichannel platforms to unify customer data, personalize interactions, and meet rising expectations…
Amplifying Workforce Development
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain…
Bora Expands Baltimore Facility, Adds Automated Fill-Finish Line
Image Credit: Adobe Stock Images/KevinRuck.com Key Takeaways To meet rising demand, Bora Pharmaceuticals is expanding its Baltimore facility by installing an automated vial, syringe, and cartridge line by 2026, enhancing its capabilities for small-scale, high-value drug production. The expansion supports…
Marken’s Precision Logistics Expedites Delivery of Critical Gene Therapies to Japan
May 28th 2025 Article When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory and temperature specifications. With precise temperature-control required at -80°C with dry ice, Marken’s teams navigated weekend…
Modeling Shared Decision-Making in Patient Communications
When Coretta learned she had stage 4 non-small cell lung cancer, she was blindsided. She didn’t fit the profile. She didn’t see it coming. And she didn’t know what to do next. It’s a common experience in serious diagnoses—patients feel…
Marken’s Precision Logistics Accelerate Life-Changing Therapy Delivery to Patient in South Korea
May 28th 2025 Article Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continuous -80°C temperature control and dry ice replenishment throughout an 80-hour transit – Marken activated a customized, precision-driven…
How Recent Executive Orders Impact the Drug Pricing Landscape
In this exclusive PC Podcast interview, Alice Valder Curran, partner at Hogan Lovells, explores: How recent executive orders—both under the Biden and Trump administrations—have reshaped the drug pricing landscape, and the legal challenges or uncertainties they present for pharmaceutical companies What life…
Being Digitally Optimized
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain…
Mercalis and PharmaCord Officially Merge, Form Valeris
Image Credit: Adobe Stock Images/Feodora.com Main Takeaways The merger of Mercalis and PharmaCord, backed by Permira and Odyssey Investment Partners, forms Valeris—a platform aimed at streamlining how life sciences companies bring therapies to market through integrated patient support, data, and…
Bridging the GenAI Adoption Gap in Supply Chain
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain…
FDA Grants Interchangeability Designation to Hadlima
Image Credit: Adobe Stock Images/PostModernStudio.com Key Takeaways Full interchangeability approved: The FDA has granted full interchangeability to Hadlima for all Humira formulations, allowing pharmacist substitution without prescriber consultation (per state law). Expanded patient access: This designation may significantly reduce out-of-pocket…
Why It’s Time to Upgrade, and What’s at Stake
The pharmaceutical industry stands at the threshold of a long-overdue transformation in how serialization is approached, implemented, and managed. For more than a decade, serialization has largely been driven by compliance, delivering solutions that meet regulatory requirements but offer limited…